Alle Storys
Folgen
Keine Story von DocCheck AG mehr verpassen.

DocCheck AG

euro adhoc: DocCheck AG
quarterly or semiannual financial statement
DocCheck has achieved an increase in sales of 15 % in the 2nd quarter

  Disclosure announcement transmitted by euro adhoc. The issuer is responsible
  for the content of this announcement.
6-month report
06.08.2007
Cologne, 6 August 2007 - In the 2nd quarter of 2007 DocCheck AG, 
Cologne, (ISIN DE0005471007 //Symbol 547100) has achieved sales 
totalling 3.5 million euro. This corresponds to an increase of 15 per
cent when compared to the 2nd quarter of 2006 (3.0 million euro). The
operating result turned out to be negative (- 106 thousand euro) and 
fell below the result for the same period in the previous year (+ 87 
thousand euro). The result per share is 0 cent (previous year: 2 
cent). Overall DocCheck AG's sales have increased by 10 per cent in 
the first six months of 2007, rising from 6.2 million euro to 6.8 
million euro. Earnings before interest and taxes (EBIT) total - 67 
thousand euro (previous year: 415 thousand euro), profit per share is
1 cent (previous year: 7 cent). Liquid funds and current-asset 
securities amounted to 14.9 million euro at the end of the 2nd 
quarter or 2.53 euro per share (previous year: 16.0 million euro or 
2.70 euro per share), due, amongst other things, to the payment of 
dividends on 28/06/2007 totalling 570 thousand euro, share buy-backs 
(272 thousand euro) and investments in additional office space (300 
thousand euro). The 2nd quarter for the DocCheck Group was marked by 
a dynamic increase in the portal and trading business on the one hand
and lower customer budgets in the agency business on the other hand. 
As already announced at publication of the 1st quarter´s results, 
some customers had reduced their marketing expenditure at the 
beginning of the year as a result of the changes to the prevailing 
statutory conditions caused by major health care reforms and the 
ensuing slight decline in the pharmaceutical market. As expected, 
sales in the agency business (antwerpes + partner) subsequently 
dropped by 3 per cent to 1.3 million euro in the 2nd quarter. The 
portal business continued to increase at a rapid pace in terms of 
development and investments and sales increased by 15 per cent to 0.8
million euro. Development in the 2nd quarter concentrated on the 
development of DocCheck-Faces, a social network software package for 
doctors which will appear in its final version as DocCheck-Service 
during the 3rd quarter. Sales in the trading business (DocCheck Shop)
increased by 49 per cent to 1.5 million euro. The outlook for the 3rd
quarter is positive. At the beginning of the 3rd quarter incoming 
orders in the agency business increased sharply, as reflected in the 
orders on the books. In particular the demand for integrated concepts
in e-marketing, Print and PR has increased and a number of new 
budgets have been acquired. At the same time the portal and trading 
business is developing according to plan. Due to the healthy business
outlook, the board of directors is expecting a positive operating 
result for the 3rd quarter with an increase in sales.
end of announcement                               euro adhoc 06.08.2007 22:00:00

Further inquiry note:

Tanja Mumme
+49 (0)221 92053 139
tanja.mumme@doccheck.com

Branche: Computing & Information Technology
ISIN: DE0005471007
WKN: 547100
Index: CDAX, Prime All Share, Technologie All Share
Börsen: Börse Frankfurt / regulated dealing/prime standard
Börse Berlin / free trade
Börse Hamburg / free trade
Börse Stuttgart / free trade
Börse Düsseldorf / free trade
Börse München / free trade

Original-Content von: DocCheck AG, übermittelt durch news aktuell

Weitere Storys: DocCheck AG
Weitere Storys: DocCheck AG
  • 29.06.2007 – 10:21

    euro adhoc: DocCheck AG / Buybacks / DocCheck AG continues to buy back shares

    Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 29.06.2007 Cologne, 29 June 2007 - On 28 June 2007 the DocCheck AG Annual General Meeting (ISIN DE0005471007 //Symbol 547100) authorised the company once again to buy back its own shares. The DocCheck AG Board of Directors is bringing the ...

  • 05.06.2007 – 20:35

    euro adhoc: DocCheck AG / Buybacks / DocCheck AG continues its share buy-back programme

    Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 05.06.2007 Cologne, 5 June 2007 - DocCheck AG (ISIN DE0005471007 //Symbol 547100) has today completed the second phase of its share buy-back programme and now holds 191,500 of its own shares, which equates to 3.2 per cent of the capital stock. ...

  • 10.05.2007 – 20:36

    euro adhoc: DocCheck AG / other / DocCheck with slightly increased sales in the 1st quarter

    Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 10.05.2007 Cologne, 10th May 2007 - DocCheck AG, Cologne (ISIN DE0005471007 // WKN 547100) achieved sales of EUR 3.3 million in the 1st quarter of 2007, representing growth of 5% over the 1st quarter of 2006 (EUR 3.1 million). Operating income ...